Table 5 Clinical outcomes.
ALL n = 74 | EP n = 43 | PD n = 31 | p-value | |
|---|---|---|---|---|
Complete resection, n (%) | 55 (74.3) | 21 (48.8) | 31 (100) | < 0.001 |
Recurrence, n (%) | 8 (10.8) | 7 (16.3) | 1 (3.2) | 0.128 |
Median duration of recurrence, month (range) | 6.2 (1.0–26.1) | 6.1 (1.0–26.1) | 15.9 (15.9) | – |
Additional treatment for recurrence, n (%) | ||||
APC | 6 (8.1) | 6 (13.9) | – | |
EP | 1 (1.4) | 1 (2.3) | – | |
Chemotherapy | 1 (1.4) | – | 1 (3.2) | |
Median length of hospital stay, day (range) | 17 (7–68) | 11 (7–57) | 42 (14–68) | < 0.001 |
Readmission, n (%) | 19 (25.7) | 12 (27.9) | 7 (22.6) | 0.788 |
Death, n (%) | 4 (5.4) | 1 (2.3) | 3 (9.7) | 0.302 |
Local recurrence | 1 (1.4) | – | 1 (3.2) | |
Pancreatic cancer | 1 (1.4) | – | 1 (3.2) | |
Heart failure | 1 (1.4) | 1 (2.3) | – | |
Herpes encephalitis | 1 (1.4) | – | 1 (3.2) | |
Median observation period, month (range) | 52.0 (6.5–157.6) | 38.8 (6.5–157.6) | 59.8 (9.3–143.6) | 0.123 |
